|
Meet option 1 and 2 or option 1 and 3: | Aged 50 to 74
/Primary lung cancer patients with pathological diagnosis and without clinical treatment or patients with pulmonary lesions highly suspicious for lung cancer and without prior treatment
|
|
Without diseases as listed following: | Diabetes
/Other malignant tumors except lung cancer
/Asthma
/Severe liver dysfunction
/End-stage renal disease
/Acute inflammation
|
|
Inform Consent Form Signature | Yes
|
- General information
- Past History
- Exhaled Breath Collection Person
- Exhaled Breath Collection Date
- Data Entry Clerk
- Data Entry Date
- Quality Control Person
- Quality Control Date
|
Case Number/ID Number | 364723 |
|
Name | WHYI |
|
Gender | Female
|
|
Age | 64 岁 |
|
Height | 156 cm |
|
Weight | 60 kg |
|
Education | University
|
|
Own Phone Number | 13060051499 |
|
Relatives Phone Number |
|
|
Relatives Name |
|
|
Smoking History | No
|
|
Drinking History | No
|
|
Surgical History | No
|
|
Family Cancer History | No
|
|
Comorbidity | No
|
|
Pulmonary Nodules on Past Chest CT | No
|
|
Exhaled Breath Collection Person | XTJ |
|
Exhaled Breath Collection Date | 2019-11-11 yyyy-mm-dd |
|
Data Entry Clerk | XTJ |
|
Data Entry Date | 2019-11-11 yyyy-mm-dd |
|
Quality Control Person |
|
|
Quality Control Date | yyyy-mm-dd |
- Tumor Marker
- FVC
- FVC%
- FEV1
- FEV1%
- FEV1/FVC
- MVV%
- DLCO SB%
- Tumor Shape on Chest CT
- Tumor Maximum Diameter on Chest CT
- Lymph Node on Chest CT
- PET-CT
|
Tumor Marker Increase |
|
FVC | 1.89 L |
|
FVC% | 80.2 % |
|
FEV1 | 1.21 L |
|
FEV1% | 61.5 % |
|
FEV1/FVC | 63.82 % |
|
MVV% | 56.3 % |
|
DLCO SB% | 90.8 % |
|
Tumor Shape on Chest CT | Ground Glass Nodule
|
|
Tumor Maximum Diameter on Chest CT | 2.5 cm |
|
Lymph Node on Chest CT | cN1-2(-)
|
|
PET-CT SUVmax | Not Done
|
|
Tumor Location | Right Lower Lobe
|
|
Surgical Approach | Two Port VATS
|
|
Type of Resection | Lobectomy
|
|
Operative Time | 160 minutes |
|
Intraoperative Blood Loss | 200 ml |
|
Intraoperative Blood Transfusion | No
|
|
Surgeon Name | Wenguang Xiao
|
|
Surgical Margin | No Residual Tumor
|
|
Pathological Type | Acinar Predominant Adenocarcinoma
|
|
Lymphovascular Invasion | No
|
|
Perineural Invasion | No
|
|
Gene Mutation | EGFR-19(+)
/ALK(-)
/ROS1(-)
/KRAS(-)
|
|
pT Stage, Eighth Edition | T1c
|
|
pN Stage, Eighth Edition | N0
|
|
Stations of N1 Lymph Nodes | Two Stations
|
|
Numbers of N1 Lymph Nodes | 3 个 |
|
Numbers of Metastatic N1 Lymph Nodes | 0 个 |
|
Stations of N2 Lymph Nodes | Two Stations
|
|
Numbers of N2 Lymph Nodes | 3 个 |
|
Numbers of Metastatic N2 Lymph Nodes | 0 个 |
|
Dissection of Station 7 | Yes
|
|
Highest N2 Status | Unknown
|
|
Types of Lymph Node Dissection | Selective Lymph Node Sampling
|
|
pM Stage, Eighth Edition | M0
|
|
pTNM Stage, Eighth Edition | Stage IA3
|
|
Postoperative Complications | No
|
|
Non-Surgical Treatment |
|
Admission Date | 2019-11-04 yyyy-mm-dd |
|
Discharge Date | 2019-11-15 yyyy-mm-dd |
|
Surgery Date | 2019-11-11 yyyy-mm-dd |